v3.26.1
Net Loss Per Share Attributable to Common Shareholders - Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Numerator:    
Net loss attributable to Kestra Medical Technologies, Ltd. $ (131,612) $ (113,814)
Undeclared preferred dividends   (12,321)
Net loss attributable to common shareholders, basic (131,612) (126,135)
Net loss attributable to common shareholders, diluted $ (131,612) $ (126,135)
Denominator:    
Weighted average shares of common share outstanding, basic [1] 54,184,698 24,583,745
Weighted average shares of common share outstanding, diluted [1] 54,184,698 24,583,745
Net loss per share attributable to common shareholders    
Net loss per share attributable to common shareholders, basic $ (2.43) $ (5.13)
Net loss per share attributable to common shareholders, diluted $ (2.43) $ (5.13)
[1]

1Weighted-average shares of common shares outstanding, basic and diluted, has been adjusted on a retrospective basis. Refer to Note 16 “Net Loss Per Share Attributable to Common Shareholders” for additional disclosure.